- Conditions: cUTI; Complicated Urinary Tract Infection; Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012 - Condition: Branch Retinal Vein Occlusion
Interventions: Drug: Ranibizumab; Procedure: Laser
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient ChildrenCondition: Pediatric Growth Hormone Deficiency
Interventions: Drug: MOD-4023; Drug: Somatropin
Sponsors: Prolor Biotech, Inc.; Prolor Biotech, Inc.
Recruiting - verified May 2012 - Condition: Infertility
Interventions: Drug: Prednisolone and Heparin during COH for IVF; Drug: COH for IVF
Sponsors: National and Kapodistrian University of Athens; National and Kapodistrian University of Athens
Recruiting - verified May 2012 - Condition: Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem; Drug: Either 500 mg of Ciprofloxacin (oral); Drug: or 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012 - Condition: Acne Vulgaris
Interventions: Device: KLOX Biophotonic System; Other: No treatment
Sponsors: KLOX Technologies Inc.; KLOX Technologies Inc.
Recruiting - verified April 2012
 |
Find Paid Clinical Trials in Greece |
Clinical Trial Locations 